Govt commits $50m for long COVID research


Tuesday, 25 April, 2023

Govt commits $50m for long COVID research

The Australian Government has announced it will provide a further $50 million from the Medical Research Future Fund (MRFF) for research into post-acute sequelae of COVID-19 (PASC), commonly known as long COVID.

This is in addition to funding that has already been provided for research related to long COVID, including more than $13 million from the MRFF, $1.6 million from the National Health and Medical Research Council and $5 million to the Australian Partnership for Preparedness Research on Infectious Disease Emergencies.

The new funding is expected to help improve our knowledge of long COVID in the Australian context and generate evidence to inform policy and clinical guidance, improve health outcomes and increase awareness of the condition in the community. The first grant opportunity is expected to open in August 2023.

The funding comes in response to the final report from the House Standing Committee on Health, Aged Care and Sport’s Inquiry into Long COVID and Repeated COVID Infections, which was tabled in the Australian Parliament yesterday. The report made a number of recommendations, which were informed by more than 560 submissions and testimonies from a wide range of sources. The Department of Health and Aged Care has now been tasked with developing a national plan to respond to long COVID, taking into consideration the committee’s findings.

Image credit: iStock.com/pilli

Related News

Accreditation Matters announces further speakers, MC

Respected journalist and presenter Steve Liebmann has been confirmed as host and MC for the...

Govt announces plan to boost medical science manufacturing

The Australian Government has released the Medical Science Co-investment Plan as part of its...

Early-bird rates and award opportunities at Accreditation Matters

It's just 11 weeks until NATA's accreditation conference, Accreditation Matters. Award...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd